Last updated on June 2018

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC


Brief description of study

The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease

Clinical Study Identifier: NCT03215706

Contact Investigators or Research Sites near you

Start Over

Site 0103

Local Institution
Osaka-sayama-shi, Japan
1.51miles
  Connect »